Biofrontera Inc. (BFRI) Stock Profile — Insider Trades & Financials

Revenue$17.1M

Net Income$5.6M

EPS$-1.67

Market Cap$11.2M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Hermann Luebbert

CEO & Executive Director

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Founded: 1997
Employees: 93
Headquarters: Woburn, Massachusetts, United States
Website

⚡

Core Efficiency

ROE?

53.82%

ROA?

19.75%

D/E Ratio?

1.73

Op. Margin?

26.66%

📊

Profitability Ratios

Net Margin?

32.98%

Loading company sections...

Biofrontera Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness